3,486
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Anti-tumor effect of local injectable hydrogel-loaded endostatin alone and in combination with radiotherapy for lung cancer

, , , , , , , , & show all
Pages 183-194 | Received 28 Oct 2020, Accepted 23 Dec 2020, Published online: 11 Jan 2021

References

  • Cao M, Chen W. (2019). Epidemiology of lung cancer in China. Thorac Cancer 10:3–7.
  • Carmeliet P, Jain RK. (2000). Angiogenesis in cancer and other diseases. Nature 407:249–57.
  • Ding RL, Xie F, Hu Y, et al. (2017). Preparation of endostatin-loaded chitosan nanoparticles and evaluation of the antitumor effect of such nanoparticles on the Lewis lung cancer model. Drug Deliv 24:300–8.
  • Gao F, Liu Y, He Y, et al. (2010). Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis. Matrix Biol 29:107–16.
  • Goel S, Duda DG, Xu L, et al. (2011). Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev 91:1071–121.
  • Gupta D, Tator CH, Shoichet MS. (2006). Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord. Biomaterials 27:2370–9.
  • Hu J, Fu S, Peng Q, et al. (2017). Paclitaxel-loaded polymeric nanoparticles combined with chronomodulated chemotherapy on lung cancer: in vitro and in vivo evaluation. Int J Pharm 516:313–22.
  • Huang S, Song X, Li T, et al. (2017). Pellet coculture of osteoarthritic chondrocytes and infrapatellar fat pad-derived mesenchymal stem cells with chitosan/hyaluronic acid nanoparticles promotes chondrogenic differentiation. Stem Cell Res Ther 8:264.
  • Jain RK. (2001). Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med 7:987–9.
  • Jiang XD, Qiao Y, Dai P, et al. (2012). Enhancement of recombinant human endostatin on the radiosensitivity of human pulmonary adenocarcinoma A549 cells and its mechanism. J Biomed Biotechnol 2012:301931.
  • Kurisawa M, Chung JE, Yang YY, et al. (2005). Injectable biodegradable hydrogels composed of hyaluronic acid-tyramine conjugates for drug delivery and tissue engineering. Chem Commun 14:4312–4.
  • Lee F, Chung JE, Kurisawa M. (2008). An injectable enzymatically crosslinked hyaluronic acid- hydrogel system with independent tuning of mechanical strength and gelation rate. Soft Matter 4:880–7.
  • Lee F, Chung JE, Kurisawa M. (2009). An injectable hyaluronic acid-tyramine hydrogel system for protein delivery. J Control Release 134:186–93.
  • Lee ST, Yun JI, Jo YS, et al. (2010). Engineering integrin signaling for promoting embryonic stem cell self-renewal in a precisely defined niche. Biomaterials 31:1219–26.
  • Li W, Zhao X, Du B, et al. (2016). Gold nanoparticle-mediated targeted delivery of recombinant human endostatin normalizes tumour Vasculature and Improves Cancer Therapy. Sci Rep 6:30619.
  • Li X, Zheng X, Wei X, et al. (2009). A novel composite drug delivery system: Honokiol nanoparticles in thermosensitive hydrogel based on chitosan. J Nanosci Nanotechnol 9:4586–92.
  • Li XQ, Shang BY, Wang DC, et al. (2011). Endostar, a modified recombinant human endostatin, exhibits synergistic effects with dexamethasone on angiogenesis and hepatoma growth. Cancer Lett 301:212–20.
  • Liu S, Chen Q, Guo L, et al. (2018). Incidence and mortality of lung cancer in China, 2008-2012. Chin J Cancer Res 30:580–7.
  • Meng MB, Jiang XD, Deng L, et al. (2013). Enhanced radioresponse with a novel recombinant human endostatin protein via tumor vasculature remodeling: experimental and clinical evidence. Radiother Oncol 106:130–7.
  • Nguyen NT, Nguyen LV, Tran NM, et al. (2019). The effect of oxidation degree and volume ratio of components on properties and applications of in situ cross-linking hydrogels based on chitosan and hyaluronic acid. Mater Sci Eng C Mater Biol Appl 103:109670.
  • Nordsmark M, Bentzen SM, Rudat V, et al. (2005). Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 77:18–24.
  • Peng F, Xu Z, Wang J, et al. (2012). Recombinant human endostatin normalizes tumor vasculature and enhances radiation response in xenografted human nasopharyngeal carcinoma models. PLoS One 7:e34646.
  • Qiu Z, Hu J, Xu H, et al. (2013). Generation of antitumor peptides by connection of matrix metalloproteinase-9 peptide inhibitor to an en-dostatin fragment. Anticancer Drugs 24:677–89.
  • Raia NR, Partlow BP, McGill M, et al. (2017). Enzymatically crosslinked silk-hyaluronic acid hydrogels. Biomaterials 131:58–67.
  • Shi J, Fan D, Dong H, et al. (2014). Anti-tumor effect of integrin targeted (177)Lu-3PRGD2 and combined therapy with Endostar. Theranostics 4:256–66.
  • Shi XX, Pang HW, Ren PR, et al. (2019). Template-assisted (192) Ir-based stereotactic ablative brachy-therapy as a neoadjuvant treatment for operable peripheral non-small cell lung cancer: a phase I clinical trial. J Contemp Brachyther 11:162–8.
  • Sun F, Yu Y, Yang Z, et al. (2018). Hyaluronic acid-endostatin2-alft1 (HA-ES2-AF) nanoparticle-like conjugate for the target treatment of diseases. J Control Release 288:1–13.
  • Tang J, Wang N, Wu J, et al. (2019). Synergistic effect and reduced toxicity by intratumoral injection of cytarabine-loaded hyaluronic acid hydrogel conjugates combined with radiotherapy on lung cancer. Invest New Drugs 37:1146–57.
  • Toole BP. (2001). Hyaluronan in morphogenesis. Semin Cell Dev Biol 12:79–87.
  • Toole BP. (2004). Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 4:528–39.
  • Ueda K, Akiba J, Ogasawara S, et al. (2016). Growth inhibitory effect of an injectable hyaluronic acid-tyramine hydrogels incorporating human natural interferon-α and sorafenib on renal cell carcinoma cells. Acta Biomater 29:103–11.
  • West DC, Kumar S. (1989). The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp Cell Res 183:179–96.
  • Wu Y, Zheng Y, Shen Z, et al. (2014). Endostar combined with radiotherapy increases radiation sensitivity by decreasing the expression of TGF-β1, HIF-1α and bFGF. Exp Ther Med 7:911–6.
  • Xiao L, Yang S, Hao J, et al. (2015). Endostar attenuates melanoma tumor growth via its interruption of b-FGF mediated angiogenesis. Cancer Lett 359:148–54.
  • Xu K, Lee F, Gao S, et al. (2015). Hyaluronidase-incorporated hyaluronic acid-tyramine hydrogels for the sustained release of trastuzumab. J Control Release 216:47–55.
  • Xu X, Jha AK, Harrington DA, et al. (2012). Hyaluronic acid-based hydrogels: from a natural polysaccharide to complex networks. Soft Matter 8:3280–94.
  • Yan M, Dongmei B, Jingjing Z, et al. (2017). Antitumor activities of liver-targeting peptide modified recombinant human endostatin in BALB/c-nu mice with hepatocellular carcinoma. Sci Rep 7:14074.
  • Yun Q, Wang SS, Xu S, et al. (2017). Use of 5-fluorouracil loaded micelles and cisplatin in thermosensitive chitosan hydrogel as an efficient therapy against colorectal peritoneal carcinomatosis. Macromol Biosci 17:1600262.
  • Zheng L, Zhang D, Chen X, et al. (2012). Antitumor activities of human placenta-derived mesenchymal stem cells expressing endostatin on ovarian cancer. Plos One 7:e39119.
  • Zheng YF, Ge W, Xu HL, et al. (2015). Endostar enhances the antitumor effects of radiation by affecting energy metabolism and alleviating the tumor microenvironment in a Lewis lung carcinoma mouse model. Oncol Lett 10:3067–72.
  • Zhu H, Yang X, Ding Y, et al. (2015). Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxia. Sci Rep 5:14503.